Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research Units
Projects & Grants
Research Output
Press / Media
Search by expertise, name or affiliation
Current standards for first-line therapy of multiple myeloma.
Sundar Jagannath
Research output
:
Contribution to journal
›
Article
›
peer-review
15
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current standards for first-line therapy of multiple myeloma.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Multiple Myeloma
100%
Thalidomide
41%
Bortezomib
41%
Melphalan
41%
Stem Cell Transplantation
35%
Prednisone
34%
Standard of Care
32%
Dexamethasone
31%
Transplantation
25%
Lenalidomide
22%
Proteasome Inhibitors
20%
Survival
18%
Vincristine
18%
Therapeutics
16%
Doxorubicin
15%
Progression-Free Survival
15%
Pharmaceutical Preparations
6%